| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |